Home › PTC Therapeutics Announces Expanded Access Program For Translarna (Ataluren)
 

Keywords :   


PTC Therapeutics Announces Expanded Access Program For Translarna (Ataluren)

2014-07-30 10:38:53| drugdiscoveryonline Home Page

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the initiation of a reimbursed expanded access program (EAP). PTC's EAP program is intended to make Translarna™ (ataluren) available to patients before commercial availability in certain countries

Tags: program access expanded announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.09Atlantic Tropical Weather Outlook
22.09Eastern North Pacific Tropical Weather Outlook
22.09Amazon says workers must be in the office. The UK government disagrees. Who is right?
22.09Eastern North Pacific Tropical Weather Outlook
22.09Atlantic Tropical Weather Outlook
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
More »